Chemotherapy in newly diagnosed primary central nervous system lymphoma

由 Hashemi-Sadraei, Nooshin, Peereboom, David M.
出版 2010

CTIM-03. PHASE II STUDY OF REGORAFENIB IN BEVACIZUMAB REFRACTORY RECURRENT GLIOBLASTOMA

由 Rauf, Yasmeen, Schilero, Cathy, Peereboom, David, Ahluwalia, Manmeet
發表在 Neuro Oncol (2020)

CMET-03. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY IN EGFR MUTANT LUNG CANCER BRAIN METASTASIS

由 Thapa, Bicky, Chao, Samuel, Pennell, Nathan, Peereboom, David, Ahluwalia, Manmeet
發表在 Neuro Oncol (2018)

BIOM-30. DECREASED B CELL AND ALTERED CD4+ T CELL SUBSET RATIO PREDICT FAVORABLE RESPONSE TO RUXOLINITIB IN HIGH-GRADE GLIOMAS

由 Rauf, Yasmeen, Jia, Xuefei, Lathia, Justin, Peereboom, David, Ahluwalia, Manmeet
發表在 Neuro Oncol (2020)

SURG-10. CONVECTION ENHANCED DELIVERY OF TOPOTECAN AND GADOLINIUM FOR RECURRENT GBM VIA THE CLEVELAND MULTIPORT CATHETER: A FIRST IN HUMAN STUDY

由 Vogelbaum, Michael, Mohammadi, Alireza, Brewer, Cathy, Peereboom, David M, Ahluwalia, Manmeet
發表在 Neuro Oncol (2017)

DR-05 TREATMENT AND PROGNOSIS AFTER BEVACIZUMAB FAILURE IN RECURRENT GLIOBLASTOMA: THE CLEVELAND CLINIC EXPERIENCE

由 Sakruti, Susmita, Vyshak, Alva, Griffith, Sandra, Stevens, Glen, Peereboom, David, Ahluwalia, Manmeet
出版 2014

ATNT-23 TEMOZOLOMIDE FOR "HIGH RISK" LOW-GRADE GLIOMA: THE CLEVELAND CLINIC EXPERIENCE

由 Sarmey, Nehaw, Murphy, Erin, Leyrer, Charles, Stevens, Glen, Peereboom, David, Ahluwalia, Manmeet
發表在 Neuro Oncol (2015)

COMP-17. LARGE-SCALE TRANSCRIPTOMIC CHARACTERIZATION OF PRIMARY AND RECURRENT GLIOBLASTOMA IDENTIFIES GENE EXPRESSION SIGNATURE OF TUMOR RESPONSE TO STANDARD THERAPY

由 Dhawan, Andrew, Lathia, Justin, Peereboom, David, Barnett, Gene, Yeaney, Gabrielle, Ahluwalia, Manmeet
發表在 Neuro Oncol (2019)

Isolated secondary CNS relapse in a case of stage I diffuse large B-cell lymphoma

由 Najjar, Yana G, Mittal, Kriti, Faza, Nadeen N, Dushkin, Holly, Peereboom, David M
出版 2014

Hyperosmolar and methotrexate therapy avoiding surgery in the acute presentation of primary central nervous system lymphoma

由 Lee, Bryan S., Juthani, Rupa G., Healy, Andrew T., Peereboom, David M., Recinos, Violette M.
出版 2014

EPID-04 PREVALENCE OF MALIGNANT PRIMARY BRAIN TUMORS IN THE UNITED STATES COMPARED TO OTHER COMMON CANCERS, 2010

由 Zhang, Adah, Ostrom, Quinn, Kruchko, Carol, Rogers, Lisa, Peereboom, David, Barnholtz-Sloan, Jill
發表在 Neuro Oncol (2015)

Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010

由 Zhang, Adah S., Ostrom, Quinn T., Kruchko, Carol, Rogers, Lisa, Peereboom, David M., Barnholtz-Sloan, Jill S.
發表在 Neuro Oncol (2017)

ACTR-09. TARGETING MYELOID DERIVED SUPPRESSOR CELLS: PHASE 0/1 TRIAL OF LOW DOSE CAPECITABINE + BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

由 Peereboom, David, Lathia, Justin, Alban, Tyler, Mohammadi, Alireza, Ahluwalia, Manmeet, Brewer, Cathy, Vogelbaum, Michael
發表在 Neuro Oncol (2018)

RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA

由 Ahluwalia, Manmeet, Peereboom, David, Schilero, Cathy, Forst, Deborah, Wong, Eric, Wen, Patrick, Reardon, David
發表在 Neuro Oncol (2018)

CTIM-20. PHASE I STUDY OF IBRUTINIB WITH RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

由 Rauf, Yasmeen, Peereboom, David, Fallah, Jaleh, Schilero, Cathy, Lackner, Pamela, Stevens, Glen, Ahluwalia, Manmeet
發表在 Neuro Oncol (2020)

CTIM-10. PHASE II STUDY OF PEMBROLIZUMAB PLUS SurVaxM FOR GLIOBLASTOMA AT FIRST RECURRENCE

由 Ahluwalia, Manmeet, Peereboom, David, Rauf, Yasmeen, Schilero, Cathy, Ciolfi, Marci, Ciesielski, Michael, Fenstermaker, Robert
發表在 Neuro Oncol (2020)

ACTR-26. SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL

由 Fallah, Jaleh, Chaudhary, Rekha, Rogers, Lisa, (Auston) Wei, Wei, Brewer, Cathy, Peereboom, David, Ahluwalia, Manmeet
發表在 Neuro Oncol (2019)

EPID-11 WHO GRADE 3 GLIOMAS: CLINICAL AND MOLECULAR PROGNOSTIC FACTORS

由 Chi, Ming, Sarmey, Nehaw, Gotterer, Lauren, Chen, Zhijian, Stevens, Glen, Peereboom, David, Elson, Paul, Ahluwalia, Manmeet
發表在 Neuro Oncol (2015)

EPID-14 OUTCOMES IN ELDERLY PATIENTS WITH HIGH GRADE GLIOMAS

由 Gotterer, Lauren, Sarmey, Nehaw, Chi, Ming, Chen, Zhijian, Stevens, Glen, Peereboom, David, Elson, Paul, Ahluwalia, Manmeet
發表在 Neuro Oncol (2015)

MPTH-04 LOMUSTINE AS SALVAGE THERAPY IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA

由 Chen, Zhijian, Chi, Ming, Sarmey, Nehaw, Gotterer, Lauren, Stevens, Glen, Peereboom, David, Elson, Paul, Ahluwalia, Manmeet
發表在 Neuro Oncol (2015)